Multifactorial Evaluation of COVID-19 Respiratory Reliquates
Sponsor
University of Turin, Italy (Other)
Overall Status
Recruiting
CT.gov ID
NCT05607069
Collaborator
(none)
50
1
12
4.2
Study Details
Study Description
Brief Summary
The present study aims to evaluate how commonly diagnostic tools employed in the preoperative evaluation of respiratory function in thoracic surgery can identify pathological alteration due to a previous SARS-CoV-2 infection. In particular, the investigators will gather information concerning imaging (lung ct and lung ultrasound), arterial blood gas analysis, and pulmonary function tests.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Multifactorial Evaluation of COVID-19 Respiratory Reliquates
Actual Study Start Date
:
May 28, 2022
Anticipated Primary Completion Date
:
May 28, 2023
Anticipated Study Completion Date
:
May 28, 2023
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
COVID-19 previous infection
|
Outcome Measures
Primary Outcome Measures
- sensibility of preoperative evaluation in identifying pathological sequelae due to SARS-Cov2 infection [12 month]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
previous SARS-Cov2 infection
-
awaiting lung resection surgery
Exclusion Criteria:
-
less than 18 years of age
-
unable to consent to enroll
-
refuse to enroll
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | AOU Città della Salute e della Scienza di Torino | Turin | Italy | 10100 |
Sponsors and Collaborators
- University of Turin, Italy
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University of Turin, Italy
ClinicalTrials.gov Identifier:
NCT05607069
Other Study ID Numbers:
- 00097/2022
First Posted:
Nov 7, 2022
Last Update Posted:
Nov 17, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: